DENTSPLY SIRONA’s (XRAY) Outperform Rating Reiterated at Barrington Research

Barrington Research reaffirmed their outperform rating on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a report released on Monday,Benzinga reports. They currently have a $14.00 price target on the medical instruments supplier’s stock.

Several other research analysts have also issued reports on XRAY. Stifel Nicolaus set a $13.00 target price on DENTSPLY SIRONA in a research report on Thursday, November 6th. JPMorgan Chase & Co. decreased their price target on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research note on Friday, November 7th. Barclays started coverage on DENTSPLY SIRONA in a research report on Monday, December 8th. They issued an “underweight” rating and a $12.00 price objective on the stock. Mizuho set a $13.00 target price on DENTSPLY SIRONA in a research report on Friday, November 7th. Finally, Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research note on Friday, September 26th. Two research analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and a consensus price target of $15.15.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $12.37 on Monday. The stock has a market cap of $2.47 billion, a price-to-earnings ratio of -2.80, a price-to-earnings-growth ratio of 0.96 and a beta of 1.00. The company has a debt-to-equity ratio of 1.36, a quick ratio of 0.99 and a current ratio of 1.47. The stock has a 50 day moving average price of $11.31 and a 200-day moving average price of $13.20. DENTSPLY SIRONA has a one year low of $9.85 and a one year high of $20.59.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.08). The company had revenue of $904.00 million for the quarter, compared to analysts’ expectations of $900.33 million. DENTSPLY SIRONA had a negative net margin of 24.34% and a positive return on equity of 17.10%. The business’s quarterly revenue was down 4.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.50 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. Equities analysts expect that DENTSPLY SIRONA will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 9th. Shareholders of record on Friday, December 26th will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 5.2%. The ex-dividend date is Friday, December 26th. DENTSPLY SIRONA’s dividend payout ratio is presently -14.48%.

Insider Activity at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier sold 82,200 shares of the company’s stock in a transaction that occurred on Monday, December 8th. The shares were sold at an average price of $11.14, for a total value of $915,708.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.50% of the company’s stock.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several institutional investors have recently bought and sold shares of the business. Bank of Montreal Can grew its stake in DENTSPLY SIRONA by 8.2% during the 2nd quarter. Bank of Montreal Can now owns 352,524 shares of the medical instruments supplier’s stock valued at $5,598,000 after purchasing an additional 26,610 shares during the last quarter. CWM LLC lifted its holdings in shares of DENTSPLY SIRONA by 84.3% during the third quarter. CWM LLC now owns 420,470 shares of the medical instruments supplier’s stock worth $5,336,000 after purchasing an additional 192,373 shares during the period. Envestnet Portfolio Solutions Inc. lifted its holdings in shares of DENTSPLY SIRONA by 36.9% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 15,460 shares of the medical instruments supplier’s stock worth $246,000 after purchasing an additional 4,165 shares during the period. AGF Management Ltd. boosted its position in DENTSPLY SIRONA by 29.6% in the second quarter. AGF Management Ltd. now owns 186,424 shares of the medical instruments supplier’s stock valued at $2,960,000 after buying an additional 42,542 shares during the last quarter. Finally, Prudential Financial Inc. increased its holdings in DENTSPLY SIRONA by 67.9% in the 2nd quarter. Prudential Financial Inc. now owns 1,158,415 shares of the medical instruments supplier’s stock worth $18,396,000 after buying an additional 468,415 shares during the period. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.